COS certificate should be essential for effective entry into European market

The successful entry of the domestic pharmaceutical firms into the European market requires the acquisition of COS (Certification of Suitability of Monographs of the European Pharmacopoeia), according to the Korea Pharmaceutical Traders Association (KPTA) and related industry.

The KPTA said that during the world pharmaceutical bulks exposition held in Paris of France recently, a number of Eu...